67 results on '"Schena, F.P."'
Search Results
2. Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression
3. IL-17 Expression by Tubular Epithelial Cells in Renal Transplant Recipients with Acute Antibody-Mediated Rejection
4. (117) - Exploring New Molecular Biomarkers in Transbronchial Biopsies from Patients with Chronic Lung Allograft Dysfunction: A Bicentric Longitudinal Study
5. Extended Criteria Donor Kidney Transplantation: Comparative Outcome Analysis Between Single versus Double Kidney Transplantation at 5 Years
6. Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease
7. ID2-VEGF-related Pathways in the Pathogenesis of Kaposi’s Sarcoma: A Link Disrupted by Rapamycin
8. A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients
9. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy
10. Ischemia–reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function
11. FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia
12. Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases
13. Confocal Laser Scanning Microscope Study of Terminal Villi Vessels in Normal Term and Pre-eclamptic Placentas
14. A general multiplex-PCR assay for the general detection of genetically modified soya and maize
15. Sirolimus-Based Therapy With or Without Cyclosporine: Long-Term Follow-up in Renal Transplant Patients
16. A Randomized Trial of Steroid Avoidance in Renal Transplant Patients Treated with Everolimus and Cyclosporine
17. Cardiovascular problems in renal failure: MO32 FETUIN-A: A POSSIBLE LINK BETWEEN SECONDARY HYPERPARATHYROIDISM (SH) AND INFLAMMATION IN THE PROGRESSION OF CARDIOVASCULAR DISEASE IN DIALYSIS PATIENTS (PTS)
18. Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients
19. Pregnancy in renal transplantation: immunologic evaluation of neonates from mothers with transplanted kidney
20. Molecular Assessment (RNA-sequencing) of CLAD in Lung Transplant Biopsies: A Pilot Study
21. Medical and surgical complications after kidney transplantation from “suboptimal donors”: one centre's experience
22. The dynamics of kidney donation: Viewpoints from the donor, the recipients, and the transplant team
23. Angiotensin converting enzyme gene polymorphism in renal transplant patients with IgA nephropathy: relationship with graft function and prevalence of hypertension
24. 342. ACE inhibition reduces risk of diabetic nephropathy: antihypertensive agents for primary prevention of diabetic nephropathy
25. APPLICABILITÀ DELLE LINEE GUIDA BASATE SULL'EVIDENZA ALLA COMUNE PRATICA CLINICA: IL SISTEMA GRADE.
26. Angiotensin IV and Renal Diseases.
27. Complement-mediated acute induction of endothelial-to-mesenchymal transition (EndMT) in a swine model of renal ischemia/reperfusion > (I/R) injury
28. Effect of Fibronectin on C3b and Fc Receptor-mediated Phagocytosis by Peripheral Blood Monocytes in Uraemic Patients.
29. Fibronectin and the Kidney.
30. Serum Profiles of the Regulatory Complement Proteins during the Progression of Renal Damage in Human Glomerulonephritis.
31. Plasma Fibronectin Levels in Patients with Chronic Uremia.
32. Activation of the Alternative Complement Pathway by Unidentified Substances in Human Glomerulonephritis.
33. Immunological and Bacteriological Studies in Chronic Pyelonephritis Associated with Kidney Stones.
34. Renal growth factors: past, present and future.
35. Acute Renal Failure During Intermittent Rifampicin Therapy.
36. Therapeutic targeting of classical and lectin pathways of Complement protects from ischemia-reperfusion induced renal damage inhibiting the activation of dendritic cells
37. A controlled clinical trial on antiviral therapy (peginterferon alfa-2A (40 KD) + ribavirin) for the treatment of chronic hepatitis C in patients on haemodialysis awaiting renal transplant
38. Pentraxin 3 (PTX3) and complement cascade activation in the failure of arteriovenous fistula (AVF) in hemodialysis (HD)
39. P.238 High sustained virological response (SVR) rates with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in haemodialysed CHC patients awaiting renal transplant
40. A controlled clinical trial on antiviral therapy (peginterferon alfa-2A (40KD)+ribavirin) for the treatment of chronic hepatitis C in patients on haemodialysis awaiting renal transplant.
41. Literature Abstracts.
42. Comparison of pathologic and normal sera by immune complex determination: Five disease groups within 190 samples are discriminated by computer-selected combinations of 13 methods: Report of the Italian committee for the study of immune complexes (WIC)
43. Long term follow-up of women with hypertension in pregnancy
44. Patterns of proteinuria in chronic pyelonephritis. The pseudo-glomerular pattern
45. Passage of human Bence Jones protein into the intestinal lumen; an isotopic and immunochemical study in the rat
46. Increased Plasma Levels of Human Atrial Natriuretic Factor in Patients Treated with Acetate or Bicarbonate Hemodialysis.
47. Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-β 1 and monocyte chemotactic protein-1 expression in human mesangial cells
48. Posttransplant erythrocytosis: A possible nonerythropoietin-mediated mechanism
49. Sub-lytic terminal complement complex (TCC) stimulates renal proximal tubular epithelial cells (PTEC) to express adhesion molecules and to secrete proinflammatory and fibrogenic mediators
50. IMMUNE COMPLEXES IN NORMAL PREGNANCY AND IN PRE-ECLAMPSIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.